Multimodal Postoperative Analgesia Following OSA Surgery
NCT ID: NCT04483427
Last Updated: 2021-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2020-09-20
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Pain and Discomfort After Orbital Decompression
NCT03562611
Different Modalities of Analgesia in Open Heart Surgeries in Mansoura University
NCT04223219
Postoperative Epidural Analgesia in Spine Fusion Surgery
NCT01838707
Single Dose Morphine and Fentanyl Added to Intrathecal Mixture on Orthopedics Patients With Undiagnosed Obstructive Sleep Apnea
NCT02014714
Ketodex Versus Opioid Based Anaesthesia in Cleft Palate Repair Ketodex Versus Opioid Based Anaesthesia in Cleft Palate Repair Ketodex Versus Opioid Based Anaesthesia in Cleft Palate Repair Ketodex Versus Opioids in Cleft Palate Repaire
NCT05402189
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OSA patients after multilevel surgery
Nalbuphine, ketorolac, accufuser
multimodal analgesic regimen consisting of nalbuphine combined with ketorolac using IV continuous infusion silicon device (Accufuser)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nalbuphine, ketorolac, accufuser
multimodal analgesic regimen consisting of nalbuphine combined with ketorolac using IV continuous infusion silicon device (Accufuser)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age between 30 - 50 years
* OSA patients diagnosed by polysomnography and stop-bang questionnaire
* enrolled for multilevel OSA surgery
Exclusion Criteria
* history of hepatic, cardiopulmonary or renal disease
* history of any chronic pain on medication
* history of substance abuse
* psychiatric disorder
* lack of patient cooperation.
30 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bahaa Mohammed Refaie
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bahaa Mohammed Refaie
Lecturer of anesthesia and ICU
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bahaa M Refaie, MD
Role: PRINCIPAL_INVESTIGATOR
Lecturer of anesthesia and ICU sohag university
Mohammed E Ahmed, MD
Role: STUDY_DIRECTOR
Lecturer of ENT sohag university
A M Elhalwagy, MD
Role: STUDY_CHAIR
Consultant of pain medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag faculty of medicine
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Bahaa M Refaie, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1984
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.